PRECISION BIOSCIENCES INC — Investor Relations & Filings
Precision BioSciences is a clinical-stage gene editing company focused on developing therapeutic candidates using its proprietary ARCUS® genome editing platform. ARCUS is a novel technology that utilizes sequence-specific DNA-cutting enzymes, or nucleases, to perform targeted edits within living cells and tissues. The platform is designed to insert (knock-in), remove (knock-out), or repair DNA sequences. The company's primary application of this technology is the development of in vivo gene editing therapies aimed at overcoming and potentially curing rare genetic diseases and other hard-to-treat conditions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-27 | English | |
| 8-K | 2026-05-26 | English | |
| 10-Q - PRECISION BIOSCIENCES INC (0001357874) (Filer) | 2026-05-05 | English | |
| 8-K - PRECISION BIOSCIENCES INC (0001357874) (Filer) | 2026-05-05 | English | |
| ARS - PRECISION BIOSCIENCES INC (0001357874) (Filer) | 2026-04-08 | English | |
| DEF 14A - PRECISION BIOSCIENCES INC (0001357874) (Filer) | 2026-04-08 | English |
Browse filings by year
11 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
IMUGENE LIMITED
Clinical-stage immuno-oncology company developing cancer im…
|
IMU | AU | Professional, scientific and te… |
|
IMV Inc.
Pioneering novel immunotherapies using the proprietary DPX®…
|
IMV | CA | Professional, scientific and te… |
|
INBIOGEN CO.,Ltd
A life sciences firm offering bioinformatics and data minin…
|
101140 | KR | Professional, scientific and te… |
|
Incannex Healthcare Inc.
A clinical-stage biopharma firm developing cannabinoid and …
|
IXHL | US | Professional, scientific and te… |
|
Indaptus Therapeutics, Inc.
Develops bacterial-based immunotherapies for cancer and vir…
|
INDP | US | Professional, scientific and te… |
|
InflaRx N.V.
Clinical-stage biopharmaceutical firm developing C5a/C5aR p…
|
IFRX | NL | Professional, scientific and te… |
|
Inhalation Sciences Sweden AB
Develops lab instruments and provides research for preclini…
|
ISAB | SE | Professional, scientific and te… |
|
Initiator Pharma A/S
Clinical-stage company developing drugs for central and per…
|
INIT | DK | Professional, scientific and te… |
|
Inmolecule Nanotech, S.A.
Develops nanoparticles from plant compounds for biomedical …
|
MLINA | ES | Professional, scientific and te… |
|
InNexus Biotechnology Inc.
Develops enhanced monoclonal antibodies and diagnostics usi…
|
IXSBF | CA | Professional, scientific and te… |
PRECISION BIOSCIENCES INC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34491/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34491 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34491 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34491 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34491}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PRECISION BIOSCIENCES INC (id: 34491)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.